
Viemed Healthcare VMD
$ 9.13
2.01%
Quarterly report 2025-Q3
added 11-05-2025
Viemed Healthcare DSO Ratio 2011-2026 | VMD
Annual DSO Ratio Viemed Healthcare
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.7 | 37.1 | 39.3 | 34.4 | 52.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 52.5 | 33.7 | 39.4 |
Quarterly DSO Ratio Viemed Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.2 | 38.6 | 39.9 | - | 42.6 | 42.8 | 38.7 | - | 33.1 | 36 | 36.6 | - | 19.1 | 18.6 | 37.4 | - | 38.7 | 42.3 | 41.2 | 36.2 | 33.8 | 26.4 | 45.8 | 49.1 | 51.7 | 51.8 | 51.3 | 43.9 | 47.6 | 58.6 | 34.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 58.6 | 18.6 | 39.7 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 38.77 | -1.27 % | $ 5.78 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 8.09 | 3.45 % | $ 581 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.1 | 2.76 % | $ 153 M | ||
|
Electromed
ELMD
|
137 | $ 24.5 | 2.17 % | $ 207 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 9.69 | 3.09 % | $ 1.31 B | ||
|
FONAR Corporation
FONR
|
237 | $ 18.54 | 0.19 % | $ 122 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 42.93 | -1.11 % | $ 1.33 B | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
40.7 | $ 29.44 | -1.31 % | $ 1.36 B | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.26 | 2.84 % | $ 113 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 13.55 | -0.37 % | $ 876 M | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 105.35 | 1.02 % | $ 1.33 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 0.52 | -0.36 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 66.26 | -3.17 % | $ 3.61 B | ||
|
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | ||
|
Pulmonx Corporation
LUNG
|
54.9 | $ 1.47 | -3.92 % | $ 57.5 M | ||
|
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.79 | -1.75 % | $ 43 M | ||
|
Medtronic PLC
MDT
|
68.8 | $ 96.0 | -0.75 % | $ 123 B | ||
|
Align Technology
ALGN
|
86.7 | $ 181.73 | -0.5 % | $ 13.6 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
48 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
76.1 | $ 3.97 | 7.88 % | $ 840 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 113.65 | 0.04 % | $ 198 B | ||
|
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 72.77 | -1.46 % | $ 108 B | ||
|
Orthofix Medical
OFIX
|
60 | $ 12.98 | -0.42 % | $ 514 M |